1233220
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Piscataway, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)